{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T15:44:34Z","timestamp":1793634274918,"version":"4.5.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82374331"],"award-info":[{"award-number":["82374331"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2023ZYD0049"],"award-info":[{"award-number":["2023ZYD0049"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.phymed.2025.156439","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T17:04:02Z","timestamp":1738083842000},"page":"156439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Zhuyu pill attenuates metabolic-associated fatty liver disease by regulating macrophage polarization through TLR4 signaling pathway"],"prefix":"10.1016","volume":"138","author":[{"given":"Mei","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingman","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyao","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruitong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Mou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0690-4444","authenticated-orcid":false,"given":"Zubing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2025.156439_bib0001","doi-asserted-by":"crossref","first-page":"G627","DOI":"10.1152\/ajpgi.00090.2022","article-title":"Hepatocyte- or macrophage-specific SREBP-1a deficiency in mice exacerbates methionine- and choline-deficient diet-induced nonalcoholic fatty liver disease","volume":"323","author":"Araki","year":"2022","journal-title":"Am. J. Physiol. Gastrointest. Liver. Physiol."},{"key":"10.1016\/j.phymed.2025.156439_bib0002","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41574-022-00675-6","article-title":"Macrophage functional diversity in NAFLD - more than inflammation","volume":"18","author":"Barreby","year":"2022","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.phymed.2025.156439_bib0003","first-page":"219","article-title":"CD36, a signaling receptor and fatty acid transporter that regulates immune cell metabolism and fate","author":"Chen","year":"2022","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.phymed.2025.156439_bib0004","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s12072-020-10094-2","article-title":"The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease","volume":"14","author":"Eslam","year":"2020","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.phymed.2025.156439_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4331\/wjbc.v9.i1.1","article-title":"Mutual interaction between oxidative stress and endoplasmic reticulum stress in the pathogenesis of diseases specifically focusing on non-alcoholic fatty liver disease","volume":"9","author":"Fujii","year":"2018","journal-title":"World J. Biol. Chem."},{"key":"10.1016\/j.phymed.2025.156439_bib0006","first-page":"eabf8271","article-title":"Inhibition of nonalcoholic fatty liver disease in mice by selective inhibition of mTORC1","volume":"376","author":"Gosis","year":"2022","journal-title":"Science (1979)"},{"key":"10.1016\/j.phymed.2025.156439_bib0007","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.metabol.2016.05.003","article-title":"Non-alcoholic fatty liver disease and dyslipidemia: an update","volume":"65","author":"Katsiki","year":"2016","journal-title":"Metabolism."},{"key":"10.1016\/j.phymed.2025.156439_bib0008","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41575-018-0082-x","article-title":"The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"16","author":"Kazankov","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.phymed.2025.156439_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106507","article-title":"Toll-like receptors and metabolic (dysfunction)-associated fatty liver disease","volume":"185","author":"Khanmohammadi","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phymed.2025.156439_bib0010","series-title":"The Intervention of Zuojin Wan Allied Ganlu San Onnonalcoholic Fatty Liver Disease of Excessive Heat Ofstomach and Yang deficiency of Liver Syndrome","author":"Li","year":"2017"},{"key":"10.1016\/j.phymed.2025.156439_bib0011","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.apsb.2019.02.006","article-title":"Silibinin ameliorates hepatic lipid accumulation and oxidative stress in mice with non-alcoholic steatohepatitis by regulating CFLAR-JNK pathway","volume":"9","author":"Liu","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.phymed.2025.156439_bib0012","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.phymed.2025.156439_bib0013","doi-asserted-by":"crossref","first-page":"119","DOI":"10.21037\/hbsn-23-556","article-title":"The global burden of fatty liver disease: the major impact of China","volume":"13","author":"Lou","year":"2024","journal-title":"Hepatobiliary. Surg. Nutr."},{"key":"10.1016\/j.phymed.2025.156439_bib0014","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/hep.23719","article-title":"Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites","volume":"52","author":"Neuschwander-Tetri","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.phymed.2025.156439_bib0015","article-title":"New targets for NAFLD","volume":"3","author":"Parlati","year":"2021","journal-title":"JHEP. Rep."},{"key":"10.1016\/j.phymed.2025.156439_bib0016","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jhep.2014.10.039","article-title":"Molecular mechanism of ppar\u03b1 action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease","volume":"62","author":"Pawlak","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phymed.2025.156439_bib0017","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.phymed.2025.156439_bib0018","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1146\/annurev-nutr-071812-161230","article-title":"Omega-3 fatty acids, hepatic lipid metabolism, and nonalcoholic fatty liver disease","volume":"33","author":"Scorletti","year":"2013","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.phymed.2025.156439_bib0019","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1872-034X.2011.00822.x","article-title":"Toll-like receptor signaling in liver regeneration, fibrosis and carcinogenesis","volume":"41","author":"Seki","year":"2011","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.phymed.2025.156439_bib0020","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1002\/ptr.7754","article-title":"Resveratrol regulates inflammation and improves oxidative stress via Nrf2 signaling pathway: therapeutic and biotechnological prospects","volume":"37","author":"Shahcheraghi","year":"2023","journal-title":"PhytOther Res."},{"key":"10.1016\/j.phymed.2025.156439_bib0021","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1016\/j.jhep.2023.07.021","article-title":"Can we use old NAFLD data under the new MASLD definition?","volume":"80","author":"Song","year":"2024","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phymed.2025.156439_bib0022","first-page":"243","article-title":"Zhuyu pill can prevent and treat atherosclerosis by promoting M2 polarization of macrophages through ppar\u03b3\/NF-\u03bab signaling pathway","volume":"49","author":"Song","year":"2024","journal-title":"Chin J Chin Mater Med"},{"key":"10.1016\/j.phymed.2025.156439_bib0023","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1158\/0008-5472.CAN-19-2994","article-title":"Enhanced lipid accumulation and metabolism are required for the differentiation and activation of tumor-associated macrophages","volume":"80","author":"Su","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.phymed.2025.156439_bib0024","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1161\/CIRCRESAHA.119.315939","article-title":"Intracellular and intercellular aspects of macrophage immunometabolism in atherosclerosis","volume":"126","author":"Tabas","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.phymed.2025.156439_bib0025","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.it.2017.03.001","article-title":"Macrophage immunometabolism: where are we (Going)?","volume":"38","author":"Van den Bossche","year":"2017","journal-title":"Trends. Immunol."},{"key":"10.1016\/j.phymed.2025.156439_bib0026","first-page":"971","article-title":"Berberine as a potential multi-target agent for metabolic diseases: a review of investigations for Berberine","volume":"21","author":"Wang","year":"2021","journal-title":"Endocr. Metab. Immune Disord. Drug Targets."},{"key":"10.1016\/j.phymed.2025.156439_bib0027","doi-asserted-by":"crossref","first-page":"29033","DOI":"10.1021\/acsomega.3c01955","article-title":"Zhuyu pill alleviates nonalcoholic fatty liver disease by regulating bile acid metabolism through the gut-liver axis","volume":"8","author":"Xu","year":"2023","journal-title":"ACS. Omega"},{"key":"10.1016\/j.phymed.2025.156439_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101501","article-title":"Non-lethal sonodynamic therapy facilitates the M1-to-M2 transition in advanced atherosclerotic plaques via activating the ROS-AMPK-mTORC1-autophagy pathway","volume":"32","author":"Yang","year":"2020","journal-title":"Redox. Biol."},{"key":"10.1016\/j.phymed.2025.156439_bib0029","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/s41467-023-37142-3","article-title":"Deficiency of gluconeogenic enzyme PCK1 promotes metabolic-associated fatty liver disease through PI3K\/AKT\/PDGF axis activation in male mice","volume":"14","author":"Ye","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phymed.2025.156439_bib0030","doi-asserted-by":"crossref","first-page":"eabq1984","DOI":"10.1126\/sciadv.abq1984","article-title":"Macrophage acetyl-CoA carboxylase regulates acute inflammation through control of glucose and lipid metabolism","volume":"8","author":"Yeudall","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.phymed.2025.156439_bib0031","first-page":"24","article-title":"Dietary evodiamine inhibits atherosclerosis-associated changes in vascular smooth muscle cells","author":"Zha","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phymed.2025.156439_bib0032","article-title":"Macrophage metabolism in nonalcoholic fatty liver disease","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phymed.2025.156439_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115405","article-title":"Uncovering the mechanism of Huanglian-Wuzhuyu herb pair in treating nonalcoholic steatohepatitis based on network pharmacology and experimental validation","volume":"296","author":"Zhang","year":"2022","journal-title":"J. Ethnopharmacol."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711325000807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711325000807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T16:30:41Z","timestamp":1740501041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711325000807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":33,"alternative-id":["S0944711325000807"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2025.156439","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Zhuyu pill attenuates metabolic-associated fatty liver disease by regulating macrophage polarization through TLR4 signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2025.156439","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"156439"}}